Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.00% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
CRDF · Sep 30, 2024
Cardiff Oncology, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0000950170-24-123242General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-6336.97% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
17.02% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-7636.97% · CORE · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
759.39% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History13 statesSelf-history eligible
Jun 30, 20230/5 normalizedLevel 3Sep 30, 20230/5 normalizedLevel 3Dec 31, 20230/5 normalizedLevel 3Mar 31, 20240/5 normalizedLevel 3Jun 30, 20244/5 normalizedLevel 3Sep 30, 20244/5 normalizedLevel 3Dec 31, 20244/5 normalizedLevel 3Mar 31, 20253/4 normalizedLevel 3Jun 30, 20254/4 normalizedLevel 3Sep 30, 20255/5 normalizedLevel 3Dec 31, 20255/5 normalizedLevel 3Mar 31, 20264/4 normalizedLevel 3Jun 30, 20264/4 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- -5662.58%
- Current
- -6336.97%
- Delta
- -674.39%
- Previous
- 50.93%
- Current
- 17.02%
- Delta
- -33.90%
- Previous
- -7696.32%
- Current
- -7636.97%
- Delta
- 59.35%
- Previous
- 723.31%
- Current
- 759.39%
- Delta
- 36.08%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · CRDF Fundamental State →Analogous To · CRDF state analogue 2 →Transitioned To · CRDF Fundamental State →Transitioned To · CRDF CASH_GENERATION_DECREASED →Transitioned To · CRDF GROWTH_DECREASED →Transitioned To · CRDF PROFITABILITY_INCREASED →Transitioned To · CRDF SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.